Q.30 Retroviruses are enveloped viruses that can be engineered to deliver how many bases of single-stranded RNA?
- 500 bases
- 1000 bases
- 3000 bases
- 8000 bases
Retroviruses can be engineered to deliver up to 8000 bases of single-stranded RNA, making this the correct answer among the options. This capacity is key for their use in gene therapy vectors.
Question Breakdown
Retroviruses are enveloped RNA viruses with a natural genome of about 7-12 kb, but engineered versions (like lentiviral vectors) have a packaging limit around 8 kb for therapeutic RNA cargo.
Option Analysis
-
500 bases: Too small; this fits microRNAs or tiny regulatory elements, not retroviral vectors which handle full genes.
-
1000 bases: Still insufficient for most transgenes; adenoviral or AAV vectors might manage this, but retroviruses exceed it.
-
3000 bases: Approaches some smaller genes but falls short of retrovirus capacity, which supports larger inserts reliably.
-
8000 bases: Correct; matches the standard limit for retroviral/lentiviral packaging of single-stranded RNA in gene delivery.
Retroviruses in Gene Therapy
Retroviruses reverse-transcribe their single-stranded RNA into DNA for host genome integration, ideal for stable expression. Engineered forms delete viral genes to fit ~8 kb foreign RNA, enabling treatments like CAR-T cells.
Retroviruses deliver 8000 bases RNA in engineered forms, a key fact for GATE Life Sciences exams. These enveloped viruses package up to 8 kb of single-stranded RNA, vital for gene therapy vectors like lentiviruses.
Retrovirus RNA Packaging Basics
Retroviruses carry two copies of positive-sense single-stranded RNA (~7-12 kb naturally). Engineering removes gag/pol/env genes, freeing ~8 kb for transgenes via reverse transcription and integration.
Capacity stems from virion structure: RNA binds Gag polyprotein, limited by capsid size. Beyond 8-10 kb, efficiency drops sharply.
Why 8000 Bases?
This limit balances payload with packaging signals (ψ sequence). Studies confirm lentiviral vectors handle 8 kb reliably for clinical use.
For GATE prep, note: smaller options (500-3000 bases) suit non-integrating vectors like AAV (~4.7 kb DNA).
Exam Relevance
From CUET PG Life Sciences 2024 PYQ: Option 4 (8000 bases) is correct. Memorize for virology sections in GATE XL.
Option Feasibility Example Use 500 bases Very small siRNA delivery 1000 bases Limited Short reporters 3000 bases Moderate Small cDNAs 8000 bases Optimal Full genes in therapy -